期刊文献+

万应胶囊与帕拉米韦联合使用对儿童流行性感冒中高热症状的影响

Effect of Wanying Capsule in Combination with Peramivir on Symptoms of Hyperthermia in Influenza in Children
下载PDF
导出
摘要 目的:评价万应胶囊联合帕拉米韦治疗有中高热症状儿童流感的临床效果和安全性。方法:选取江西省儿童医院2022年1月至2022年11月共计72例有中高热症状流感患儿为研究对象,依据计算机生成随机数字表,按照就诊顺序对患儿进行随机分组,分A、B组各36例。A组患儿一般治疗+帕拉米韦抗病毒治疗。B组患儿在A组治疗的基础上联合口服万应胶囊治疗。分别于治疗前、治疗1天~3天分别观察和记录患儿的体温、症状总计分(TSS)和、血常规和C反应蛋白(CRP)以及不良反应发生情况。结果:治疗1天~3天后,B组的完全退热时间和退热起效时间显著短于A组(均P<0.05),B组TSS总计分降低更明显(P<0.05),B组咽痛中、重度患儿的比例明显降低(P<0.05);治疗后白细胞和中性粒细胞及CRP较治疗前均明显降低,且B组CRP水平较对照组降低明显(P<0.05)。治疗1天~3天后,B组的布洛芬日使用量和频次均少于A组(均P<0.05)。2组患儿均未出现不良事件,肝功能和肾功能化验室检查均未出现异常。结论:万应胶囊治疗有中高热症状小儿流感安全性佳,可减轻炎症反应,改善发热和咽喉肿痛等症状,缩短病程,万应胶囊口服联合帕拉米韦氯化钠注射液效果更显著。 Objective:To evaluate the clinical efficacy and safety of Wanying Capsules combined with peramivir in the treatment of influenza in children with moderate to high fever.Methods:A total of 72 children with moderate and high fever symptoms from January 2022 to November 2022 in Jiangxi Children’s Hospital were selected as the research subjects,and the children were randomly divided into 36 cases in group A and B according to the computer-generated random number table.General treatment for children in group A and peramivir antiviral therapy.Group B children were treated with oral Wanying Capsules in addition to group A treatment.Before treatment,observe and record the child’s temperature,total symptom score(TSS),blood routine and C-reactive protein(CRP),and the occurrence of adverse reactions for 1~3 days before treatment.Results:After 1~3 days of treatment,the complete antipyretic time and antipyretic onset time of group B were significantly shorter than those in group A(P<0.05),the total TSS score of group B decreased more significantly(P<0.05),the proportion of moderate and severe sore throat in group B was significantly reduced(P<0.05);Compared with before treatment,leukocytes,neutrophils and CRP were significantly decreased after treatment,and CRP level in group B was significantly decreased compared with control group(P<0.05).After 1~3 days of treatment,the daily use and frequency of ibuprofen in group B were less than those in group A(all P<0.05).There were no adverse events in the two groups,and there were no abnormalities in liver function and renal function laboratory examinations.Conclusion:Wanying Capsules have a good safety profile in the treatment of influenza in children with medium and high fever symptoms,which can reduce inflammation,improve symptoms such as fever and sore throat,and shorten the course of the disease,and the oral combination of universal capsules combined with paramivir sodium chloride injection is more effective.
作者 朱春晖 徐晗 Zhu Chunhui(Jiangxi Children’s Hospital,Nanchang Jiangxi 330006)
机构地区 江西省儿童医院
出处 《黑龙江医药》 CAS 2023年第5期1004-1008,共5页 Heilongjiang Medicine journal
基金 国家自然科学基金资助项目(编号:8146017) 江西省儿童感染疾病临床研究中心支持江西省儿童医院青年人才“双培养”科研项目关于“重症流感的早期识别、个体化诊疗方案及其机制探讨”课题(编号:SPBKT2020007) 江西省中医药管理局科技计划课题“万应胶囊治疗儿童急性上呼吸道感染中高热单中心、随机、平行对照临床研究”。
关键词 儿童流行性感冒 万应胶囊 帕拉米韦 临床效果 安全性 Influenza in children Wanying Capsules Paramivir Clinical effect Security
  • 相关文献

参考文献8

二级参考文献177

共引文献411

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部